FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
Intra-Cellular Therapies (NASDAQ: ITCI) reported Q3 EPS of ($0.22), $0.06 better than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Intra-Cellular Therapies (ITCI) click here.
... More
